Get ACNS Braindumps & ACNS Real Exam Questions [Q86-Q110]

Section	Weight	Objectives
Topic 1: Foundations of Advanced Practice	8-12%	– Advanced Practice Role Development – Evidence-Based Practice Principles – Professional Ethics and Legal Issues – Healthcare Policy and Advocacy – Theoretical Foundations of Nursing
Topic 2: Systems and Outcomes	10-15%	– Healthcare Delivery Systems – Resource Management and Cost-Effectiveness – Regulatory Compliance and Standards – Risk Management and Quality Assurance – Healthcare Informatics and Technology
Topic 3: Clinical Expertise in Adult Health	40-50%	– Health Assessment and Promotion – Diagnostics and Laboratory Interpretation – Therapeutic Interventions and Treatments – Pharmacology for Adult Populations – Acute and Chronic Disease Management – Pathophysiology and Clinical Management
Topic 4: Education and Research	10-15%	– Data Analysis and Outcome Measurement – Patient and Staff Education – Research Utilization and Evidence Appraisal – Clinical Scholarship and Publication
Topic 5: Leadership and Consultation	15-20%	– Healthcare Leadership Principles – Quality Improvement and Patient Safety – Change Management and Innovation – Interprofessional Team Collaboration – Consultation and Collaboration Skills

NO.86 What medication and dose can be used for abortive therapy in an adult client with symptoms of migraine headache?

ergotamine (Ergostat) 2 mg SL

ketorolac (Toradol) 100 mg IM

sumatriptan (Imitrex) 6 mg IM

amitriptyline (Elavil) 100 mg PO

When treating an adult client experiencing migraine headaches, several medications can be utilized as abortive therapy to alleviate symptoms. Among these options, ergotamine, sumatriptan, and ketorolac are notable choices, each with specific dosages and administration routes tailored to effectively manage migraine attacks.
Ergotamine (Ergostat) is a well-established medication for abortive migraine therapy. It is typically administered sublingually at a dose of 2 mg. Ergotamine works by constricting peripheral and cranial blood vessels and reducing the hyperactivity of the trigeminal nerves, which are associated with migraine pain. The sublingual form ensures quick absorption and rapid onset of action, which is crucial for the effective treatment of acute migraines.
Ketorolac (Toradol) is another option for the abortive treatment of migraine. This medication is a nonsteroidal anti-inflammatory drug (NSAID) that helps reduce inflammation and pain. For migraine attacks, ketorolac can be administered intramuscularly with a typical dose ranging from 30-60 mg. The intramuscular route of administration provides a fast-acting effect, making it suitable for severe migraine episodes.
Sumatriptan (Imitrex) is also widely used in treating migraines. It belongs to a class of medications known as triptans, which specifically target serotonin receptors to reduce inflammation and constrict blood vessels, thereby relieving migraine symptoms. Sumatriptan can be administered subcutaneously at a dose of 6 mg for rapid relief from migraine. This route ensures quick drug absorption and onset of action, which is essential during acute migraine attacks.
It is important to note that amitriptyline (Elavil), although used in migraine management, is not typically employed as abortive therapy but rather as a preventive treatment. Amitriptyline is an antidepressant that can help reduce the frequency and severity of migraines when taken regularly at doses like 100 mg orally; however, it does not provide immediate relief of symptoms once a migraine has started. Each of these medications serves a specific role in managing different aspects of migraine attacks. The choice of drug and dosage should be tailored to the individual patient’s medical history, severity of symptoms, and response to previous treatments, under the guidance of a healthcare provider.

NO.87 The CNS is treating a patient who has been prescribed allopurinol for gout. He has facial swelling, and blisters on his mouth nose and eyes. He tells her that he has had a sore throat and fever for a few days. Which of the following conditions would you suspect?

shingles

meningococcemia

rocky mountain spotted fever

Stevens-Johnson syndrome

NO.88 In your career, you will encounter many professional journal articles with important data for your review. The CNS knows that the difference between the smallest and largest observation is the:

first degree of freedom

range

absolute value

standard deviation

NO.89 You are managing a patient who has irritable bowel syndrome (IBS). Altering the gut pain threshold in IBS is a possible therapeutic outcome with the use of:

amitriptyline (Elavil)

loperamide (Immodium)

dicyclomine (Bentyl)

metrodionazole (Flagyl)

In managing a patient with irritable bowel syndrome (IBS), one of the therapeutic goals can be to alter the gut pain threshold, which is the level at which pain is perceived in the gastrointestinal tract. This alteration can help in reducing the discomfort experienced by patients due to abdominal pain, which is a common symptom in IBS.
Amitriptyline (Elavil), a low-dose tricyclic antidepressant (TCA), is an effective option for this purpose. TCAs, including amitriptyline, work by modulating neurotransmitters in the central nervous system, which in turn can help to increase the pain threshold in the gut. This modulation involves the blocking of the reuptake of serotonin and norepinephrine, enhancing their availability, and thereby potentially alleviating pain by reducing the sensitivity of the gut nerves. The effectiveness of amitriptyline in IBS may be attributed to its properties of altering central and peripheral pain mechanisms and its anticholinergic effects, which can relax smooth muscle spasms and reduce bowel overactivity.
Other medications such as loperamide (Imodium) and dicyclomine (Bentyl) are also used in the management of IBS but serve different purposes. Loperamide is primarily used to manage diarrhea by slowing intestinal motility and increasing the absorption of fluid in the intestines. Dicyclomine is an antispasmodic that helps in relieving muscle spasms in the gastrointestinal tract, thereby reducing abdominal pain associated with IBS, but it does not alter the pain threshold like amitriptyline.
Metronidazole (Flagyl), another medication mentioned, is not typically used in the treatment of IBS. Instead, it is an antibiotic used for treating certain types of infectious colitis and other bacterial infections. It does not have a role in altering the gut pain threshold or managing the primary symptoms of IBS.
In summary, amitriptyline (Elavil) is particularly noted for its ability to alter the gut pain threshold in patients with IBS, which can lead to significant relief from abdominal pain. This makes it a valuable option in the therapeutic regimen for IBS, especially in cases where pain is a predominant and debilitating symptom.

NO.90 Most states require advanced practice nurses to have which type of work environment?

Independent.

Adjusted.

Collaborative.

Traditional.

The correct answer to the question regarding the type of work environment most states require for advanced practice nurses (APNs) is “Collaborative.” This requirement is based on the regulations that govern the scope of practice for APNs, which can vary significantly from one state to another.
In the context of advanced practice nursing, collaboration typically means that the nurse works in conjunction with a physician or other healthcare providers. This collaborative model is designed to enhance patient care by integrating the unique skills and knowledge of each provider. It often involves formal agreements that outline the roles and responsibilities of each party, ensuring that the healthcare delivery is safe, effective, and compliant with state laws.
The necessity for collaboration may be rooted in several factors. One is the level of autonomy granted to APNs, which can differ based on state laws. Some states allow APNs full practice authority, meaning they can practice independently without any required collaboration with a physician. These states recognize that APNs are capable of making complex clinical decisions and managing patient care autonomously.
However, most states still require some level of physician oversight, whether through direct supervision or a collaborative agreement. This oversight might include regular consultation, review of patient cases, or co-signature on certain medical orders. The terminology used to describe these relationships can vary, including words like “collaboration,” “delegation,” or “supervision.” The collaborative requirement is based on the belief that a team approach can lead to better patient outcomes. It leverages the strengths and expertise of both physicians and APNs, fostering a comprehensive approach to healthcare that benefits patients through improved access to care and a broadening of available services.
In summary, while the landscape of APN practice authority is evolving, with a trend towards greater independence in some regions, the prevailing requirement across most states remains a collaborative work environment. This model ensures that APNs are part of a healthcare team that delivers high-quality medical care, ultimately benefiting the broader health system and patient population.

NO.91 Which of the following may be administered to a patient who is presenting an arrhythmia after an MI?

Disopyramide

Nitroglycerin

Heparin

Pindolol

Disopyramide is a medication used to treat certain types of serious (life-threatening) irregular heartbeat such as persistent ventricular tachycardia. It works by slowing the electrical conduction in the heart, stabilizing the heart rhythm, and maintaining a regular, steady heartbeat. Following a myocardial infarction (MI), or heart attack, patients may develop arrhythmias, which are abnormalities in the rhythm of the heart. Disopyramide can be administered to these patients to help manage these arrhythmias, particularly if they are symptomatic or pose a risk to the patient’s health.
Nitroglycerin, on the other hand, is primarily used to manage angina (chest pain) and other conditions where the heart muscle is not getting enough blood. It works by dilating blood vessels to improve blood flow. While nitroglycerin does help alleviate chest pain associated with a heart attack, it does not directly address arrhythmias and hence is not typically used solely for arrhythmia management post-MI.
Heparin is an anticoagulant, or a blood thinner, used to prevent the formation of blood clots. After a heart attack, the risk of blood clots increases, which can lead to further heart damage or complications like stroke. Although heparin is critical in the acute management of myocardial infarction to prevent further clotting, it does not directly treat arrhythmias. Its use is vital in the overall management of heart attack patients but not specifically for correcting abnormal heart rhythms.
Pindolol is a type of beta-blocker used to treat high blood pressure and chest pain, but it is also effective in some cases for controlling heart rate in patients with arrhythmia. Beta-blockers can be helpful post-MI for reducing the workload on the heart and improving survival rates. However, their primary role is not to restore normal heart rhythm but rather to manage the underlying conditions contributing to heart disease and to prevent further cardiac events.
In summary, among the options provided, disopyramide is specifically suited for treating arrhythmias that may occur after a myocardial infarction. It directly targets the electrical impulses of the heart to stabilize the heart’s rhythm, making it an appropriate choice for arrhythmia management in this context.

NO.92 When caring for a patient nearing the end of life, it can sometimes be helpful to ask the patient about significant events and people in his or her life. This allows the patient to see the good he or she has done in life, to recall important memories, and to put his or her life in context. This exercise is known as which of the following?

Life assessment.

Life review.

Spiritual assessment.

Spiritual review.

The practice you are referring to is commonly known as a “Life Review.” This therapeutic approach is especially meaningful in end-of-life care, where it serves multiple purposes both for the patient and their caregivers.
A life review is an organized reflection of a patient’s life experiences, significant personal accomplishments, and poignant moments. It offers the patient an opportunity to evaluate their life’s events, to reconcile any unresolved issues, and to recognize their life’s impact and value. By recalling fond memories and significant life events, patients often find a sense of peace, accomplishment, and closure.
The process of conducting a life review can vary; it might be informal, such as conversations with caregivers or family, or more structured, involving specific prompts or guided storytelling. The key is to encourage the patient to tell their story in their own way, focusing on significant events, people, and memories.
The benefits of life review are manifold. Psychologically, it helps patients deal with issues such as regret or guilt, providing a more settled emotional state. Spiritually, it can alleviate distress by helping patients find meaning and purpose in their life events, thus fostering a sense of peace as they approach the end of life. Socially, it allows family members and caregivers to connect more deeply with the patient, enhancing their understanding and empathy for the patient’s life journey.
In addition to these benefits, life review can be a tool for spiritual assessment. Caregivers can gain insights into the spiritual needs of the patient, which can guide further support and care interventions. This can be particularly important in palliative care settings, where addressing spiritual distress is a key component of holistic care.
Overall, life review is a valuable practice in end-of-life care. It not only supports the patient in summarizing and celebrating their life but also assists caregivers and family members in understanding the patient’s life story, thereby enhancing the care and support they provide during this critical time.

NO.93 The cleansing of the stomach with solution delivered through a nasogastric tube is known as what?

Gavage.

Emesis.

Lavage.

Stomach pumping.

NO.94 Which of the following managed care organizations has the LEAST control of managed care?

Network Independent Practice Association (IPA).

Preferred provider organization.

Fee-for-service.

Staff/group Health Maintenance Organization (HMO).

In the context of healthcare, the term “managed care” refers to a variety of techniques intended to reduce the cost of providing health benefits and improve the quality of care. It is characterized by arrangements with healthcare providers to provide care to members at reduced costs. These healthcare systems contrast significantly in terms of how much control they exert over services, costs, and the management of care.
Among the options provided-Network Independent Practice Association (IPA), Fee-for-service, Preferred Provider Organization (PPO), and Staff/Group Health Maintenance Organization (HMO)-the Fee-for-service (FFS) model has the least control over managed care. This is because the Fee-for-service model compensates providers for each service, such as tests and procedures, rather than providing care under a fixed fee or capitation system, which is common in other forms of managed care systems.
In a Fee-for-service system, healthcare providers are paid individually for each service they perform. This can lead to increased usage of healthcare services since providers are incentivized to perform more treatments and procedures as they will receive more payments. Consequently, there is less control over the overall use and cost of medical care, which contrasts with managed care models that seek to control costs and manage care more effectively through structured provider networks and set payment arrangements.
On the other hand, models like HMOs, PPOs, and IPAs have more structured systems. HMOs usually employ or partner closely with a network of providers to provide care for members at a fixed annual or monthly fee, thus controlling costs and managing care more tightly. PPOs, while allowing for more provider flexibility, still negotiate rates with providers and may offer incentives for members to use network providers. IPAs manage member care by contracting with independent physicians who continue to operate their own offices but must meet the IPA’s standards and cost controls.
Thus, when comparing these models, the Fee-for-service system stands out as having the least control over managed care, focusing primarily on the volume of services rather than the coordination and overall management of patient care. This lack of control can lead to higher healthcare costs and less efficient care management.

NO.95 The Adult Clinical Nurse Specialist works for an organization that conducts research. The name given to the subjects in a research study who do not have the disease or condition that is being studied, but who are included in the study for comparison are:

controls

case series

cross sectionals

placebos

In clinical research, particularly in studies aiming to ascertain the effectiveness of a treatment or intervention, it’s crucial to have a proper comparison group alongside the group receiving the treatment. This comparison group is referred to as “controls.” These are individuals who do not have the disease or condition that the primary study group has, or who do not receive the intervention being tested. They are essential for providing a baseline against which the effects of the intervention can be measured.
Controls help researchers understand what changes would have occurred without the intervention. For example, in a clinical trial testing a new drug for diabetes, the control group would consist of participants who either receive a standard treatment for diabetes or a placebo (a substance with no therapeutic effect). This comparison ensures that any differences in outcomes between the control group and the treatment group can be attributed to the intervention itself, rather than other variables.
In contrast, other research terms have different functions: – A **case series** is a type of observational study that involves detailed reporting of symptoms, signs, diagnosis, treatment, and follow-up of a group of patients with a particular diagnosis, without a control group for comparison. – A **cross-sectional study** examines the relationship between diseases and other variables of interest as they exist in a defined population at one particular time. This type of study provides a ‘snapshot’ of the frequency and characteristics of a disease in a population at a specific point in time. – A **placebo** is an inactive substance or treatment that looks the same as, and is administered in the same way as, the drug or treatment being tested. It is used to control for the placebo effect, a psychological benefit derived from the expectation of improvement, rather than the characteristics of the actual drug.
Therefore, in the context of a clinical trial or research study, the term “controls” specifically refers to those individuals who serve as a baseline or standard for comparison against the group receiving the experimental treatment. This comparison is critical for the validity and reliability of the study’s conclusions about the effectiveness and safety of the treatment under investigation.

NO.96 Which of the following is most consistent with the diagnosis of anxiety?

diminished cognitive ability

nausea

consistent early morning wakening

difficulty initiating sleep

To understand why “difficulty initiating sleep” is most consistent with the diagnosis of anxiety, it’s important to delve into the relationship between anxiety and sleep disturbances. Anxiety disorders involve excessive and persistent worry, fear, or nervousness. These intense feelings of anxiety can activate the body’s stress response, often termed as the ‘fight or flight’ response, which prepares the body to either confront or flee from perceived threats. This response is associated with a variety of physiological changes including increased heart rate, heightened senses, and a surge in adrenaline.
These physiological changes can significantly impact an individual’s ability to initiate sleep. When the brain is in a heightened state of alertness due to anxiety, it becomes difficult for it to transition into the calm and relaxed state necessary for sleep onset. This is why difficulty initiating sleep is commonly reported among individuals with anxiety disorders. The mind continues to race with thoughts, often worrying or ruminating about past events or anticipating future problems, which can prevent the relaxation needed for sleep.
While other symptoms such as nausea or consistent early morning awakening may also occur in individuals with anxiety, they are not as directly linked to the disorder as difficulty initiating sleep. Nausea can be a symptom of many conditions including anxiety, but it is also commonly associated with gastrointestinal disorders, medications, or other illnesses. Consistent early morning awakening could suggest other sleep-related disorders like insomnia or could be influenced by depression, another condition often comorbid with anxiety but distinct in its sleep disturbance patterns.
In summary, while anxiety can manifest in various physical and psychological symptoms, difficulty initiating sleep is particularly illustrative of the disorder due to the direct interference of anxiety’s physiological and cognitive effects with the mechanisms of sleep initiation. This makes it a key symptom for clinicians to consider when diagnosing anxiety. The heightened state of alertness and the inability to relax, both characteristic of anxiety, are what primarily contribute to this sleep initiation difficulty.

NO.97 Of the following, which is the rarest type of shock?

Septic.

Anaphylactic.

Acute adrenal insufficiency.

Neurogenic.

In medical emergencies, various types of shock can occur, each with distinct causes and mechanisms. The rarest among these is neurogenic shock.
To understand why neurogenic shock is considered rare, it is essential to compare it with other types of distributive shock such as septic shock, anaphylactic shock, and acute adrenal insufficiency.
Septic shock is one of the more commonly encountered types of shock in medical settings. It occurs when an overwhelming infection leads to systemic inflammation and widespread vasodilation, which impairs the ability of blood vessels to maintain adequate tone and pressure. This type of shock is frequently seen in patients with compromised immune systems or those with severe infections.
Anaphylactic shock is another type of distributive shock that occurs rapidly in response to an allergen. This reaction can be triggered by foods, medications, or insect stings, leading to the sudden release of histamine and other inflammatory mediators that cause severe vasodilation and increased vascular permeability. This type of shock, while severe, is generally more common because of the widespread prevalence of allergies among the population.
Acute adrenal insufficiency shock occurs when there is a sudden deficiency in corticosteroids, often due to abrupt discontinuation of corticosteroid therapy or less commonly, due to adrenal gland failure. This results in inadequate glucocorticoid and mineralocorticoid production which are crucial for maintaining vascular tone and fluid balance.
Neurogenic shock, on the other hand, is specifically caused by trauma to the spinal cord which disrupts the normal autonomic pathways that control blood vessel tone. The loss of sympathetic tone leads to unopposed parasympathetic activity, resulting in severe vasodilation and hypotension. This type of shock is rare because it requires a specific type of injury to the spinal cord, typically at or above the level of the sixth thoracic vertebra.
The rarity of neurogenic shock is also highlighted by its narrow set of causes compared to other shocks that have broader and more varied etiologies. Given its specific cause related to spinal injuries, it is less frequently encountered in the general population unlike septic or anaphylactic shock, which can be triggered by more common events such as infections or allergies.
In conclusion, neurogenic shock’s classification as the rarest type of shock among the options provided is due to its specific causality linked with significant trauma to the spinal cord, a less common occurrence compared to the triggers for other types of distributive shock.

NO.98 You are seeing a young adult female who comes to the clinic and tells you she was raped late last night by her date. The immediate action taken by the CNS is:

Accompany her to the emergency department for an exam.

Call her family so they can be with her.

Perfom a pelvic examination to determine her injuries.

Send her immediately for counseling to help her deal with this situation.

When a young adult female reports that she was raped, the immediate and appropriate action for the Clinical Nurse Specialist (CNS) is to accompany her to the emergency department for a comprehensive examination. The emergency department is equipped with personnel who are specifically trained in conducting forensic examinations, which are crucial in these situations. These professionals have the expertise to meticulously collect and preserve evidence that is essential for legal proceedings, should the victim choose to pursue them.
Performing the examination in an emergency setting rather than a regular office or clinic is vital because it ensures that the evidence needed for a legal case, should the victim decide to press charges, is collected according to the required legal standards. This includes the collection of physical evidence, documentation of injuries, and possibly the administration of prophylactic treatments for sexually transmitted infections and emergency contraception.
Moreover, the CNS should ensure that the patient is treated with sensitivity and respect throughout the process. It is important that the victim has control over the subsequent steps following their disclosure of the incident. This includes deciding whether or not to notify family or friends. The CNS should also provide information on available rape crisis resources, including counseling and support groups, which can offer the necessary emotional support and guidance moving forward.
While it might seem appropriate to immediately address physical injuries or to provide counseling, these actions should be secondary to ensuring that the victim receives a proper forensic examination at the emergency department. Immediate counseling without addressing the need for a forensic exam might inadvertently compromise the collection of crucial evidence. Therefore, the priority is to first secure the forensic and medical needs at an emergency facility, followed by emotional and psychological support in the aftermath of the incident.
In summary, the CNS’s role in this scenario is to provide immediate support by facilitating access to specialized care in the emergency department, preserving the patient’s right to choose further actions, and ensuring access to comprehensive services that address both the immediate and long-term needs following an assault.

NO.99 Which of the following is most likely to be used to diagnose acute arterial occlusion?

Angiography.

Cardiac catheterization.

MRI.

CT scan.

NO.100 When treating a patient with a history of resolved hepatitis A infection, you also note that her laboratory results show hepatitis B surface antigen (HBsAg) positive. This is most consistent with which of the following?

no evidence of hepatitis B infection

a resolved hepatitis B infection

evidence of effective hepatitis B immunization

chronic hepatitis B infection

*P When evaluating a patient who shows a positive hepatitis B surface antigen (HBsAg), it is important to understand what this indicates in the context of hepatitis B infection. The presence of HBsAg is a key marker used to identify current hepatitis B virus (HBV) infection. HBsAg is the first serological marker to appear in the blood following infection with HBV and can be detected as early as 1 to 10 weeks before clinical symptoms become apparent, and it often persists for several months or longer. *P The presence of HBsAg suggests a few possible scenarios: 1. **Acute Hepatitis B Infection:** If the HBsAg is positive and the patient shows symptoms of hepatitis (like jaundice, fatigue, abdominal pain), it might indicate an acute infection. However, this is typically accompanied by the presence of hepatitis B core antigen (HBcAg) and IgM antibodies to HBcAg. 2. **Chronic Hepatitis B Infection:** If the HBsAg remains positive for more than 6 months, this indicates a chronic hepatitis B infection. Chronic HBV infection is characterized by the persistence of HBsAg and can lead to more serious health issues like cirrhosis or liver cancer if not managed properly. *P The other serological markers associated with hepatitis B include: – **Hepatitis B surface antibody (HBsAb):** This antibody indicates recovery and immunity from HBV infection. It is also present after successful vaccination against hepatitis B. – **Hepatitis B core antibody (HBcAb):** Appears at the onset of symptoms in acute HBV infection and persists for life. The presence of IgM antibody to HBcAb indicates recent infection (acute), while IgG antibody indicates past or chronic infection. *P Given that the patient has a positive HBsAg, the most consistent interpretation is chronic hepatitis B infection. This is because: – There is no current evidence of hepatitis B resolution, as HBsAg would not be present in resolved infections. – There is no evidence to suggest effective immunization, as a positive HBsAb (not HBsAg) would be the marker indicating immunity from vaccination. *P It is crucial to differentiate between these markers to correctly diagnose and manage the patient’s condition. Chronic hepatitis B infection requires monitoring and potentially antiviral therapy to prevent progression to more severe liver disease. In conclusion, the positive HBsAg in this patient most consistently points to an ongoing chronic hepatitis B infection.

NO.101 When discussing Human Immunodeficiency virus (HIV) testing with a patient, the CNS knows:

Sexually active homosexual men are the only ones at risk for HIV.

Receiving blood products from 1985 to 1995 is a risk factor for HIV.

The screening ELISA test (enzyme-linked immunosorbent assay) detects antibodies and is 99% sensitive and specific.

There is no need to recheck the ELISA if negative on the first test.

The correct answer is: “The screening ELISA test (enzyme-linked immunosorbent assay) detects antibodies and is 99% sensitive and specific.” It is important to clarify why this statement is correct and to address the misconceptions around HIV risk and testing. Firstly, the ELISA test is a widely used initial screening tool for detecting antibodies to HIV. Antibodies are proteins that the body produces in response to an infection. In the case of HIV, these antibodies generally develop within a few weeks to months after infection. The sensitivity and specificity of the ELISA test being around 99% means that the test is highly effective at correctly identifying those who have and do not have HIV. A test with 99% sensitivity will correctly identify 99% of people with the disease and miss 1%, while a test with 99% specificity will correctly rule out the disease in 99% of people who do not have the disease, mistakenly identifying 1% as positive.
Addressing the first statement, it is a misconception that only sexually active homosexual men are at risk for HIV. HIV can affect anyone, regardless of sexual orientation, age, race, or any other factor. It is transmitted through contact with infected bodily fluids such as blood, semen, vaginal fluids, and breast milk. This can happen through unprotected sexual activities with an infected person, sharing needles for drug use, receiving unsafe injections, transfusions, and from mother to child during childbirth or breastfeeding.
Furthermore, the statement about rechecking the ELISA test highlights the concept of the “window period.” The window period is the time immediately after infection during which antibodies to HIV are not yet produced in high enough quantities to be detectable by the test. Therefore, if exposure to HIV is suspected, a follow-up test is recommended after the window period, typically around six months, to confirm the initial result. This protocol helps in capturing cases that might have been missed if tested too early after exposure.
Lastly, it is crucial to recognize broader risk factors beyond sexual orientation. Individuals with multiple sexual partners, those who engage in IV drug use, people with a history of sexually transmitted diseases (STDs), and those who were recipients of blood products between 1975 and 1985 (before widespread screening of the blood supply for HIV began) are also at increased risk. Understanding these factors can help in better targeting education, prevention, and testing efforts to those most at risk.
In summary, the CNS (Clinical Nurse Specialist) must be equipped with accurate and comprehensive knowledge about HIV transmission, testing, and the populations at risk. This ensures appropriate guidance and management of patients concerning HIV testing and prevention strategies.

NO.102 Which of the following manufactures glycogen from food that is not carbohydrate?

Glycogenolysis.

Glyconeogenesis.

Glycogenesis.

Glyconeolis.

NO.103 The CNS understands that the primary purpose of a pre-employment physical examination is:

to determine the mental status of the applicant

to document any existing disabilities and recommend accommodations

to identify existing health problems that might adversely affect the company’s insurance rates

to determine if the applicant is physically capable of doing the job

NO.104 The CNS is prescribing a prostaglandin analog for his patient. Of the following, which would the CNS prescribe?

Travatan 0.004%.

Zaditor 0.25%.

Debrox 6.5%.

Atropine.

NO.105 You are educating a patient with Type II diabetes mellitus. The Adult Clinical Nurse Specialist understands that secondary causes of hyperglycemia include the use of all of the following medications except:

niacin

thiazide diuretics

angiotensin receptor blockers

corticosteroids

When educating a patient with Type II diabetes mellitus about medications that can affect their blood glucose levels, it is vital to identify which drugs might cause secondary hyperglycemia. Secondary hyperglycemia occurs when an external factor, such as medication, increases a person’s blood glucose levels, complicating the management of their diabetes.
Niacin, a form of Vitamin B3 used to treat high cholesterol, is one of the medications known to increase blood sugar levels. This effect occurs because niacin can impair glucose tolerance, leading to elevated glucose levels in the blood.
Thiazide diuretics, often prescribed for hypertension, can also lead to increased blood glucose levels. They decrease insulin sensitivity which can result in hyperglycemia, especially important to monitor in patients managing Type II diabetes.
Corticosteroids, used for their anti-inflammatory properties in various conditions, can significantly impact glucose metabolism. They promote gluconeogenesis and reduce the peripheral utilization of glucose, thereby raising blood sugar levels. This is particularly challenging for diabetic patients as it can exacerbate their condition.
On the other hand, angiotensin receptor blockers (ARBs), which are also prescribed for hypertension, do not adversely affect blood glucose levels. ARBs work by blocking the action of angiotensin II, which is a substance in the body that increases blood pressure and can also increase blood sugar levels indirectly through other mechanisms. However, ARBs specifically do not have a direct effect on blood glucose levels and are considered safe for use in diabetic patients. This makes them a preferred choice for managing hypertension in individuals with concomitant Type II diabetes.
In conclusion, while educating a patient with Type II diabetes, it is crucial to stress the importance of medication awareness, especially concerning drugs like niacin, thiazide diuretics, and corticosteroids, which can exacerbate hyperglycemia. Angiotensin receptor blockers, however, do not have this effect and are safe to use without impacting glucose levels, making them suitable for diabetic patients with high blood pressure.

NO.106 A 50 year old patient with hypertension has taken 25 mg of hydrochlorothiazide daily for the past 4 weeks. His blood pressure has decreased form 155/95 to 145/90. How should the nurse practitioner proceed?

Increase the hydrochlorothiazide to 50 mg daily.

Add a drug from another class to the daily 25 mg hydrochlorothiazide.

Stop the hydrochlorothiazide and start a drug from a different class.

Continue the hydrochlorothiazide at 25 mg daily.

A 50-year-old patient with hypertension who has been taking 25 mg of hydrochlorothiazide daily for the past 4 weeks has shown a decrease in blood pressure from 155/95 mm Hg to 145/90 mm Hg. Although there has been a reduction in blood pressure, the current level still exceeds the generally recommended target of below 140/90 mm Hg for adults, particularly for those at increased risk of cardiovascular events due to conditions like hypertension.
Given this situation, the nurse practitioner needs to consider the next steps in management to effectively control the patient’s blood pressure. Simply continuing the current regimen of 25 mg of hydrochlorothiazide is not adequate as the patient’s blood pressure remains above the target levels. Moreover, doubling the dose of hydrochlorothiazide to 50 mg daily is not advisable either. This is because the incremental benefit in blood pressure reduction may be minimal with an increased dose, and higher doses of hydrochlorothiazide can lead to undesirable effects such as significant potassium loss, which can have serious consequences including cardiac arrhythmias.
An alternative strategy would be to add a medication from a different antihypertensive class to the current regimen. This approach is supported by guidelines that suggest combination therapy can be more effective in achieving blood pressure targets, especially in patients whose blood pressure is not controlled on a single drug. Adding a drug from another class, such as an ACE inhibitor, angiotensin II receptor blocker, calcium channel blocker, or a beta-blocker, can offer synergistic effects. This means that the drugs work together in different ways to lower blood pressure more effectively than either agent alone.
The rationale behind using combination therapy includes various mechanisms of action provided by different drug classes that address different physiological pathways involved in blood pressure regulation. For example, while hydrochlorothiazide reduces blood volume through its diuretic effect, an ACE inhibitor can enhance blood vessel relaxation and reduce blood vessel constriction by inhibiting the production of angiotensin II, a potent vasoconstrictor.
In conclusion, the most suitable course of action for this patient, considering the current blood pressure levels and the initial response to hydrochlorothiazide, would be to maintain the current dose of hydrochlorothiazide and add a second antihypertensive agent from a different class. This approach should be monitored closely to assess effectiveness and tolerance, ensuring that the patient achieves the target blood pressure without significant side effects. Regular follow-up and possibly lifestyle advice regarding diet, exercise, and weight management should also be part of the comprehensive management plan for this patient.

NO.107 The CNS understands that she will be treating patients with Title XIX Medicaid of the Social Security Act. The following are accurate statements regarding Medicaid with the exception of:

This is a federal and state matching program.

Medical assistance is provided to low income persons under this.

Medicaid pays for health care and prescription drugs.

Providers are allowed to collect from these patients if Medicaid denies the claim.

The question pertains to understanding the rules and regulations regarding Medicaid, which is covered under Title XIX of the Social Security Act. This federal program is designed to assist with medical costs for people with limited income and resources, and it offers benefits not typically covered by Medicare, such as nursing home care and personal care services.
One of the statements provided in the question is that “Providers are allowed to collect from these patients if Medicaid denies the claim.” This statement is incorrect and serves as the correct answer to the question. In the Medicaid program, providers who accept Medicaid patients must agree to accept Medicaid’s payment as the full payment for their services. If Medicaid denies the claim, the provider generally cannot bill the patient for the denied charges. This rule is in place to protect low-income patients from incurring medical bills they cannot afford, which they might face if Medicaid denies payment and providers are allowed to charge them directly.
Medicaid operates as a joint federal and state program. The federal government provides part of the funding, while states must match a percentage of that funding. Each state administers its own Medicaid program but must follow federal guidelines. The state’s flexibility allows it to determine aspects such as the type, amount, duration, and scope of services, which can vary widely between states.
The intention behind Medicaid rules, including the prohibition against billing patients for covered services when claims are denied, is to ensure that financial barriers do not prevent vulnerable populations-such as low-income individuals, the elderly, disabled, blind, and families with dependent children-from accessing necessary medical care. Providers who participate in Medicaid accept these terms, which includes accepting the Medicaid reimbursement as payment in full, thereby agreeing not to pursue additional payment from the patient for any services that Medicaid is supposed to cover.
In summary, the correct answer to the question, “Providers are allowed to collect from these patients if Medicaid denies the claim,” is a misstatement about Medicaid’s regulations. Providers are indeed not allowed to bill Medicaid patients directly if Medicaid denies the claim, provided the services are ones that Medicaid is expected to cover and the provider has accepted the terms of Medicaid payments. This is fundamental to ensuring that Medicaid fulfills its role in helping those who are financially disadvantaged to receive necessary healthcare.

NO.108 You are conducting an assessment with a patient who has come in after having severe diarrhea for three days. This patient is at risk for which of the following?

Fluid retention deficit.

Fluid volume deficit.

Fluid volume excess.

Malnutrition.

When assessing a patient who has experienced severe diarrhea for three days, it is crucial to consider the potential risk of fluid volume deficit. Diarrhea leads to a significant loss of water and electrolytes from the body, which, if not adequately replaced, results in a state of dehydration. This condition is termed fluid volume deficit.
Fluid volume deficit occurs when the body loses both water and electrolytes (like sodium and potassium) in greater amounts than it takes in. This can happen due to excessive diarrhea, where large volumes of fluid are expelled rapidly. It’s essential to understand that the body needs a certain volume of fluid to function correctly, as fluids are vital for maintaining blood pressure, enabling cellular functions, and facilitating the transport of nutrients and waste products.
The risk associated with fluid volume deficit includes decreased perfusion to vital organs, which can lead to complications such as hypovolemic shock, renal failure, and electrolyte imbalances. These conditions can be life-threatening if not addressed promptly. Symptoms of fluid volume deficit can include dry mucous membranes, decreased skin turgor, low urine output, lethargy, dizziness, and hypotension.
On the contrary, fluid retention deficit, sometimes confused with fluid volume deficit, isn’t a recognized medical term. People may mistakenly use it when they mean either fluid retention or fluid volume deficit. Fluid retention, or fluid overload, is the opposite condition where the body retains more fluid than it excretes, which isn’t typically a direct concern following diarrhea unless there is an underlying pathological condition affecting fluid balance, such as heart or kidney disease.
In the case of severe diarrhea, the immediate concern is almost always the risk of fluid volume deficit. Treatment involves rehydration, often with oral rehydration solutions or intravenous fluids, depending on the severity, to replace lost fluids and electrolytes. Additionally, identifying and treating the underlying cause of diarrhea is crucial to prevent further health complications.
Therefore, in clinical practice, assessing the fluid status and managing fluid volume deficit effectively is pivotal in the care of patients suffering from severe diarrhea to prevent complications and aid in recovery. This emphasizes the need for healthcare providers to be vigilant and proactive in their approach to patients presenting with symptoms of potential dehydration and fluid loss.

NO.109 Report ____ immediately if a patient has an EVD (external ventricular drain).

ICP.

CSF output.

Hypertension.

All of the above.

In patients with an external ventricular drain (EVD), monitoring and reporting intracranial pressure (ICP) is crucial. An EVD is typically used to measure ICP and to drain cerebrospinal fluid (CSF) to relieve pressure within the brain. Elevated ICP can indicate worsening of brain edema, hemorrhage, or other complications that could threaten the patient’s life. Immediate reporting of abnormal ICP values ensures timely intervention to prevent severe brain injury or death.
Changes in CSF output should also be reported immediately. The rate of CSF drainage through an EVD can provide vital information about the current status of brain swelling or the presence of blood or infection in the CSF. Sudden increases, decreases, or cessation of CSF flow can indicate blockage, infection, or changes in brain tissue position, necessitating urgent medical attention.
Hypertension in patients with an EVD is a critical issue. Elevated blood pressure can exacerbate brain swelling and increase ICP, posing a significant risk of brain herniation. Conversely, hypotension can lead to reduced cerebral perfusion pressure and result in brain tissue ischemia. Both conditions require immediate adjustments in medical management, including the potential administration of vasoactive drugs to stabilize blood pressure.
Monitoring and immediate reporting of oxygen levels in patients with an EVD are essential. Hypoxia (low oxygen levels) can worsen brain injury by promoting further swelling and increasing ICP. Ensuring adequate oxygenation is a fundamental part of the care for patients with brain injuries and those with an EVD in place. Any deviations from normal oxygen levels should be addressed promptly to optimize brain recovery and function.
By closely monitoring these parameters-ICP, CSF output, blood pressure, and oxygen levels-and reporting any critical changes immediately, healthcare professionals can provide effective and responsive care to patients with an EVD, potentially improving outcomes in critical neurological conditions.

NO.110 A patient who has normocytic anemia may MOST likely also have a history of which condition?

Rheumatoid arthritis.

Osteoarthritis.

Abnormal lipid levels.

Upper respiratory infections.

Anemia is a condition characterized by a deficiency in the number or quality of red blood cells, which are crucial for transporting oxygen throughout the body. There are various types of anemia, each with different causes and characteristics. Normocytic anemia, specifically, is a type where the red blood cells are of normal size and shape but are reduced in number. This type of anemia can occur in various contexts, one of which is associated with chronic inflammatory conditions, such as rheumatoid arthritis.
Rheumatoid arthritis (RA) is a chronic autoimmune condition that primarily affects joints but can also have systemic effects, including the development of anemia. The link between RA and normocytic anemia is primarily due to the chronic inflammation caused by the autoimmune disorder. This inflammation can lead to the production of certain cytokines and other inflammatory mediators that interfere with the production of red blood cells in the bone marrow, a condition commonly referred to as anemia of chronic disease or anemia of inflammation.
The inflammatory cytokines in RA, such as tumor necrosis factor (TNF) and interleukin-6 (IL-6), can affect the bone marrow’s ability to produce red blood cells efficiently. They also impact the hormone erythropoietin, which is crucial for the production of red blood cells. In addition, these mediators increase hepcidin production, a hormone that inhibits iron absorption and results in decreased iron availability for red blood cell production. This disruption in iron homeostasis further contributes to the development of normocytic anemia.
Given the direct impact of inflammatory processes on red blood cell production, patients with rheumatoid arthritis are at a higher risk of developing normocytic anemia. This type of anemia in RA patients can result in increased fatigue, weakness, and reduced physical capacity, which compounds the challenges already posed by the joint symptoms of RA.
In contrast, conditions like osteoarthritis, which is primarily a degenerative joint disease without systemic inflammation, abnormal lipid levels, or upper respiratory infections, typically do not cause normocytic anemia. These conditions do not generally involve the same level of systemic inflammation or the same biological mechanisms that interfere with red blood cell production as seen in rheumatoid arthritis.
Therefore, when considering the history of a patient with normocytic anemia, rheumatoid arthritis emerges as a likely associated condition due to its inflammatory nature and its known effects on hematopoiesis (formation of blood cellular components). Understanding this association is crucial for the effective management of both conditions and improving patient outcomes.

Nursing ACNS Exam Syllabus Topics:

Leave a Reply Cancel reply